Purchase Order HHSF223201710325P
Award Date
8/24/17
Potential Completion Date
12/31/22
Potential Value
$1.6M
Federal Agency
Food and Drug Administration
Awardee
Bruker Biospin Corp
Ultimate Awardee
Bruker Corporation
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a $879,190.00 firm fixed price purchase order to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, to upgrade the agency's 500 and 700 MHz nuclear magnetic resonance (NMR) spectrometers. The contract, which does not have a set-aside designation, will provide new equipment, including a new cryoprobe, backup room temperature probe, and automated sample changers, to improve the sensitivity and...
The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp, a subsidiary of Bruker Corporation, a $110,097.30 firm-fixed-price purchase order to provide an automatic sample changer and compatible probe for a Bruker 400 MHz nuclear magnetic resonance (NMR) spectrometer. The award has an August 17, 2024 completion date and was made on September 16, 2022. Bruker Biospin Corp is a for-profit manufacturer of scientific instruments and equipment. The company...
This $2,670,476.00 firm fixed price purchase order was awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments and provider of specialized equipment, maintenance, and support services to U.S. federal government agencies. The contract is for the provision of nuclear magnetic resonance (NMR) spectrometers, upgrades, maintenance, and related support services. It does not have a set-aside designation. Bruker Biospin Corp has previously...
The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp, a manufacturer of scientific instruments, a $398,050.00 firm-fixed-price purchase order contract to provide an NMR 400 console upgrade and deuterium probe. The contract was not set aside. Bruker Biospin Corp is a subsidiary of Bruker Corporation, which provides specialized equipment, maintenance, and support services to various U.S. federal government agencies. This award supports the FDA's...
Bruker Biospin Corp, a manufacturer of scientific instruments and subsidiary of Bruker Corporation, has been awarded a firm fixed price purchase order totaling $210,321.52 by the Department of Health and Human Services' Food and Drug Administration. The contract is for preventative maintenance and repair services for a Bruker Avance III 600 MHz nuclear magnetic resonance spectrometer located in Jamaica, New York through December 18, 2022. No set-aside designation was used for this award to...
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a manufacturer of scientific instruments and equipment, for the delivery of a Cryo Probe for Nuclear Magnetic Resonance (NMR) analysis. The contract has a potential value of $187,725.00 and a completion date of December 31, 2020. Bruker Biospin Corp is a subsidiary of Bruker Corporation, which provides specialized equipment, maintenance, and support...
This is a $93,143.40 fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for a Bruker Avance III 500 MHz NMR service contract. The contract has a period of performance through September 16, 2021 and is not associated with a larger contract vehicle or set-aside designation. Bruker Biospin Corp is a provider of nuclear magnetic resonance (NMR) spectrometers, maintenance, and support services to...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for a "QUADRUPLE RESONANCE INVERSE (QCI) DETECTION CRYOPROBE FOR HQC HCNP". The contract has a ceiling value of $383,068.32 and an ultimate completion date of May 1, 2022. The contract is not set aside for a specific business type. Bruker Biospin Corp has a history of providing specialized equipment, maintenance, and...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, in the amount of $238,161.00. The contract is for the delivery of a cryogenically-cooled 13C direct detect probe and 3 years of preventative maintenance for an existing Bruker nuclear magnetic resonance (NMR) spectrometry system. There was no set-aside designation for this award. The original...
This is a $159,767.50 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for the provision of a Bruker Avance III 500 MHz Nuclear Magnetic Resonance (NMR) system. The contract has no set-aside designation and is for the service and maintenance of this specialized scientific equipment used by the FDA. Bruker Biospin Corp has a history of providing NMR systems, upgrades, and support services...